Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes – PR Newswire (press release)
Health Newstrack Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 DiabetesPR Newswire (press release)Immunogenicity-related events, including urticaria, were more common among Victoza-treated patients than among comparator-treated patients in clinical …Liraglutide approved for type 2 diabetesTheHeart.OrgFDA Approves Once-Daily LiraglutideMedPage Todayall 424 news articles »

